Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Christopher J, Anker"'
Autor:
Luke M. Higgins, Nataniel H. Lester-Coll, Steven Ades, Maura M. Barry, Edward C. Borrazzo, Eric K. Ganguly, Christopher J. Anker
Publikováno v:
Journal of Gastrointestinal Oncology. 14:480-493
Autor:
Sam Afshari, Christopher J. Anker, Hannah Z. Kooperkamp, Brian L. Sprague, Nataniel H. Lester-Coll
Publikováno v:
American Journal of Clinical Oncology. 46:271-275
Autor:
Michael D. Chuong, Christopher J. Anker, Michael H. Buckstein, Maria A. Hawkins, Jordan Kharofa, Ann C. Raldow, Nina N. Sanford, Andrzej Wojcieszysnki, Jeffrey R. Olsen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:545-552
Autor:
Carl J. Nelson, MD, Nataniel H. Lester-Coll, MD, Puyao C. Li, MD, Havaleh Gagne, MD, Christopher J. Anker, MD, Matthew A. Deeley, PhD, H. James Wallace, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100613- (2021)
Externí odkaz:
https://doaj.org/article/62eaa8f1d8d74f0f940de8a1370fcf7c
Autor:
Waqas Jehangir, Alexander Karabachev, Jackie Tsao, Christopher J. Anker, Sree Susmitha Garapati, Janusz K. Kikut, Hibba Tul Rehman
Publikováno v:
Case Reports in Oncological Medicine, Vol 2021 (2021)
Paragangliomas are rare neuroendocrine tumors that arise from chromaffin-containing tissue. Surgical resection and/or radiation are used for locoregional disease, and reduction of tumor burden with systemic therapy is reserved for metastatic disease.
Externí odkaz:
https://doaj.org/article/18cdb0ce09a34c919a4b501fe0bf57d8
Autor:
Leila T. Tchelebi, Krishan R. Jethwa, Anna T. Levy, Christopher J. Anker, Timothy Kennedy, Elliot Grodstein, Christopher L. Hallemeier, Salma K. Jabbour, Ed Kim, Rachit Kumar, Percy Lee, William Small, Vonetta M. Williams, Navesh Sharma, Suzanne Russo
Publikováno v:
American Journal of Clinical Oncology. 46:73-84
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:1178-1180
Autor:
Meriem, Mokhtech, Joseph A, Miccio, Kimberly, Johung, Michael, Cecchini, Stacey, Stein, Amol K, Narang, Joseph M, Herman, John, Kunstman, Michael G, Haddock, Christopher J, Anker, Salma, Jabbour, Christopher L, Hallemeier, Krishan R, Jethwa
Publikováno v:
American Journal of Clinical Oncology. 45:450-457
Chemotherapy followed by margin-negative resection (R0) is the treatment of choice for patients with localized pancreatic ductal adenocarcinoma (PDAC). Neoadjuvant multiagent chemotherapy (MAC) or MAC then radiotherapy (RT) may optimize surgical cand
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma
Autor:
Rachit, Kumar, Leila, Tchelebi, Christopher J, Anker, Navesh, Sharma, Nancy A, Bianchi, Jadranka, Dragovic, Karyn A, Goodman, Joseph M, Herman, Yixing, Jiang, William E, Jones, Timothy J, Kennedy, Percy, Lee, Madappa, Kundranda, Suzanne, Russo, William, Small, Wonsuk W, Suh, Nelson, Yee, Salma K, Jabbour
Publikováno v:
American Journal of Clinical Oncology. 45:391-402
The objective of this study was to systematically evaluate the data regarding the use of neoadjuvant, perioperative, surgical, and adjuvant treatment options in localized gastric cancer patients and to develop Appropriate Use Criteria recommended by
Autor:
Ryan G. Payne, Christopher J. Anker, Brian L. Sprague, Hyunsoo J. No, Steven H. Lin, Nataniel H. Lester-Coll
Publikováno v:
Clinical Lung Cancer. 23:226-235
Data describing outcomes for patients with early stage lung cancer who undergo expectant management is lacking, despite evidence of a sub-population with indolent malignancies. We used the National Cancer Data Base (NCDB) to identify factors associat